WllyBIOTirzepatide
Ordered Tirzepatide from WllyBIO? Mail in a sample (US only) and let us test it for free.
Test my supplyWllyBIO Tirzepatide shows early volatility, including a 0 mg identity failure and sub-99.5% purity misses, despite a cleaner recent streak. The main caveat is absent batch IDs across reports; April fills run -9% to +3%.
Domain timing, Hong Kong registry searches, CMS fingerprints and a sister-domain storefront point away from WllyBIO’s public origin story. The report traces sales personas, payment rails and import exposure without treating the brand as a simple pass/fail call.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including WllyBIO rows.
Cancel anytime
Ordered Tirzepatide from WllyBIO? Mail in a sample (US only) and let us test it for free.
Test my supplyAbout WllyBIO test results from Finnrick
WllyBIO is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 6 peptides and 44 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible WllyBIO peptides in this dataset are BPC-157 (5 tests), GHK-Cu (6 tests) and Ipamorelin (3 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 44 recent tests.
Ordered Tirzepatide from WllyBIO? Mail in a sample (US only) and let us test it for free.
Test my supply